New Data Inform but Don't Confirm Incretin Diabetes Drugs SafetyNew Data Inform but Don't Confirm Incretin Diabetes Drugs Safety
Two new studies find that incretin-based drugs for the treatment of type 2 diabetes don't cause pancreatic cancer in the short term, but some may raise the risk of heart failure. Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
More News: Cancer | Cancer & Oncology | Cardiology | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Heart Failure | Incretin Therapy | Pancreas | Pancreatic Cancer | Study